Skip to main content
Skip to main content
IREHF logo

Integrated Research Limited (IREHF)

$0.24 +$0.06 (+33.33%) |CouncilHOLD · 47 · C
Bottom line: HOLD — our Council read (47/100) and AI Score (47/100) broadly agree.
MCap: $43.34M| Vol: 14.3K| 52-wk range: $0.18 – $0.37
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Integrated Research Limited (IREHF) trades at $0.24 with AI Score 47/100 (Grade C). Integrated Research Limited (IREHF) is an Australian software company specializing in performance management and monitoring solutions for mission-critical IT systems, unified communications, and payment networks. Market cap: $43.34M, Sector: Technology.

Price live · AI analysis from Jun 15, 2026
Integrated Research Limited (IREHF) is an Australian software company specializing in performance management and monitoring solutions for mission-critical IT systems, unified communications, and payment networks. Its core product, Prognosis, offers deep operational insight to a global clientele across approximately 60 nations.

Analyst Coverage for IREHF: IREHF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IREHF against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 47/100 · C

IREHF: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Integrated Research Limited (IREHF) Technology Profile & Competitive Position

CEOIan Lowe
Employees142
HeadquartersNorth Sydney, AU
IPO Year2013

Integrated Research Limited, headquartered in Australia, delivers specialized software solutions for managing mission-critical IT, unified communications, and payment systems globally. Its Prognosis platform provides comprehensive monitoring and management capabilities, serving a diverse institutional client base across 60 countries, including banks and telecommunications providers.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 15, 2026

What Is the Investment Thesis for IREHF?

Integrated Research Limited (IREHF) presents a compelling profile as a specialized software provider in the mission-critical IT management space, evidenced by its robust Gross Margin of 76.4% and a P/E ratio of 7.04. The company's Prognosis platform addresses the increasing enterprise reliance on stable unified communication and payment systems, a market trend identified as a potential strength. With a global presence across 60 nations and a diverse client base including financial institutions and telecommunications providers, IREHF demonstrates significant market penetration. The adoption of a Software as a Service (SaaS) model offers recurring revenue potential and scalability. However, its OTC Other tier listing introduces risks related to liquidity and disclosure. Future growth is anticipated from the ongoing digital transformation driving demand for robust performance monitoring and the expansion of its SaaS offerings. Investors should assess the company's ability to capitalize on these market trends while navigating the inherent risks of its OTC market classification.

Based on FMP financials and quantitative analysis

IREHF Key Highlights

  • Gross Margin of 76.4% indicates strong profitability on its software and services, significantly exceeding many industry benchmarks.
  • Profit Margin of 10.7% reflects efficient cost management relative to its revenue, contributing to overall financial health.
  • A P/E ratio of 7.04 suggests the stock may be undervalued compared to broader technology sector averages, warranting further investigation into its earnings potential.
  • A Dividend Yield of 7.27% highlights the company's commitment to returning capital to shareholders, potentially appealing to income-focused investors.
  • A Beta of 1.51 indicates higher volatility relative to the overall market, suggesting greater potential price swings for IREHF shares.

Who Are IREHF's Competitors?

IREHF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
NOW ServiceNow, Inc. $108.69 +2.23% $112.09B 71
RSASF RESAAS Services Inc. $0.30 +2.76% $25.04M 69
CSAI Cloudastructure Inc. $0.36 +0.47% $6.84M 68
PDFS PDF Solutions, Inc. $56.75 -4.11% $2.34B 68
USER UserTesting, Inc. $7.50 -0.13% 63
JAXAF Vinyl Group Ltd $0.05 +0.00% $74.16M 63
RCT RedCloud Holdings plc $0.24 +0.13% $10.78M 63
XM Qualtrics International Inc. $18.15 +0.06% $11.01B 63

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are IREHF's Key Strengths?

  • Specialized focus on mission-critical IT, unified communications, and payment systems monitoring.
  • Strong gross margin of 76.4% indicating efficient operations and pricing power.
  • Global presence with direct sales offices and channel partners in approximately 60 nations.
  • Diverse and high-profile clientele including stock exchanges, banks, and telecommunications providers.
  • Adoption of a Software as a Service (SaaS) model for recurring revenue and scalability.

What Are IREHF's Weaknesses?

  • Relatively small employee base (142 employees) for a global software company, potentially limiting scale and rapid expansion.
  • Trading on the OTC Other tier, which implies potentially limited liquidity and higher risk profile.
  • Disclosure status on OTC market is 'Unknown', which can deter institutional investors seeking transparency.
  • High Beta of 1.51 suggests higher stock price volatility compared to the broader market.
  • Reliance on the Prognosis platform as a primary product, potentially concentrating business risk.

What Could Drive IREHF Stock Higher?

  • Continued expansion of the Software as a Service (SaaS) adoption for its Prognosis platform, driving predictable recurring revenue growth.
  • Increasing global demand for robust unified communications and payment network performance monitoring solutions, directly benefiting IREHF's core offerings.
  • Strategic partnerships or integration agreements with major cloud providers or UC platform vendors to expand market reach and interoperability.
  • Successful penetration into new geographic markets or vertical industries, leveraging its existing global sales infrastructure and channel partners.
  • Introduction of enhanced features or modules for Prognosis, such as AI-driven predictive analytics, to maintain competitive differentiation and attract new clients.

What Are the Key Risks for IREHF?

  • Increased competition from larger enterprise software companies or emerging specialized monitoring solution providers, potentially impacting market share and pricing power.
  • The inherent risks associated with trading on the OTC Other tier, including limited liquidity, potential price volatility, and challenges in accessing comprehensive financial disclosures.
  • Economic downturns or reduced IT spending by key client sectors (e.g., financial services, telecommunications) could negatively impact software license sales and service contracts.
  • Rapid technological advancements in IT infrastructure and cloud computing requiring continuous investment in research and development to keep Prognosis competitive and relevant.
  • Fluctuations in foreign exchange rates, given the company's global operations and sales across approximately 60 nations, could affect reported financial performance.

What Are the Growth Opportunities for IREHF?

  • **Expansion in Unified Communications (UC) Monitoring:** The global unified communications market is projected to continue its robust expansion, driven by the increasing adoption of remote work, hybrid models, and the demand for seamless collaboration tools. As businesses rely more heavily on platforms like Microsoft Teams, Zoom, and Cisco Webex, the need for sophisticated monitoring and performance management solutions, such as Prognosis, becomes critical. Integrated Research Limited can capitalize on this by enhancing its UC monitoring capabilities, integrating with emerging platforms, and targeting enterprises that require guaranteed service quality for their communication infrastructure. This market segment represents a significant and ongoing growth avenue, with enterprises continuously investing in optimizing their communication ecosystems.
  • **Growth in Payment Network Management:** The digital payments industry is experiencing explosive growth worldwide, fueled by e-commerce, mobile payments, and the proliferation of fintech innovations. As transaction volumes and complexity surge, the stability and performance of payment networks are paramount for financial institutions and credit card companies. Prognosis's specialized capabilities in payment ecosystem management position Integrated Research Limited to capture a larger share of this market. By offering solutions that ensure real-time visibility, fraud detection, and compliance, IRL can attract new clients and deepen relationships with existing ones, leveraging the critical nature of payment processing to drive demand for its monitoring software.
  • **Increased Adoption of Software as a Service (SaaS) Model:** The shift towards subscription-based software delivery continues to accelerate across all enterprise software sectors. Integrated Research Limited's existing SaaS offering for its Prognosis platform provides a significant growth opportunity. By actively promoting and expanding its SaaS adoption, the company can benefit from more predictable recurring revenue streams, lower upfront costs for customers, and enhanced scalability. This model allows for broader market reach, particularly to smaller and medium-sized enterprises that may prefer operational expenditure over capital expenditure, thereby expanding IRL's addressable market and fostering long-term customer relationships.
  • **Geographic Expansion and Channel Partner Leverage:** Integrated Research Limited already boasts a global presence with direct sales offices in key regions and an international network of channel partners. A strategic growth opportunity lies in further penetrating underserved or rapidly growing markets, particularly in emerging economies where digital infrastructure is expanding. By strengthening its channel partner network through training, incentives, and co-marketing initiatives, IRL can efficiently extend its reach without significant capital expenditure. Focusing on regions with high growth in financial services and telecommunications can unlock new customer segments and drive substantial revenue growth over the next 3-5 years.
  • **Diversification into New Business Applications Monitoring:** While Prognosis is strong in UC and payment systems, its core capability of providing operational insight across distributed server architectures and business applications offers a pathway for diversification. Integrated Research Limited can expand its market by tailoring Prognosis to monitor performance for other critical enterprise applications, such as CRM, ERP, or supply chain management systems. As businesses increasingly rely on a complex web of interconnected applications, the demand for holistic performance monitoring will grow. This strategy involves identifying high-value application segments and developing specialized connectors or modules for Prognosis, broadening its appeal beyond its traditional strongholds.

What Opportunities Does IREHF Have?

  • Increasing reliance of businesses on stable communication platforms and secure payment systems driving demand for monitoring solutions.
  • Expansion of SaaS offerings to capture a larger share of the market seeking subscription-based software.
  • Geographic expansion into emerging markets with growing digital infrastructure and financial services sectors.
  • Potential for strategic partnerships or acquisitions to broaden product portfolio or market reach.
  • Leveraging AI and machine learning to enhance Prognosis's predictive analytics and automation capabilities.

What Threats Does IREHF Face?

  • Intense competition from larger enterprise software vendors and other specialized monitoring solution providers.
  • Regulatory changes or increased scrutiny for OTC-listed companies impacting investor confidence and compliance costs.
  • Economic downturns or reduced IT spending by key client sectors like financial services and telecommunications.
  • Technological obsolescence if Prognosis fails to keep pace with rapid advancements in IT infrastructure and cloud technologies.
  • Cybersecurity threats and data breaches impacting customer trust and the integrity of its software solutions.

What Are IREHF's Competitive Advantages?

  • Specialized Expertise: Deep domain knowledge in monitoring mission-critical systems, unified communications, and payment networks, which are highly complex and regulated environments.
  • Prognosis Platform: A comprehensive and proven monitoring and management platform with a long track record, offering unique operational insight.
  • Global Presence and Diverse Client Base: Established direct sales offices and a channel partner network across 60 nations, serving a broad range of blue-chip institutional clients.
  • High Switching Costs: Integration of Prognosis into mission-critical systems often leads to high switching costs for customers, fostering long-term relationships.
  • SaaS Offering: Provides flexibility and recurring revenue potential, adapting to modern software consumption preferences and expanding market reach.

What Does IREHF Do?

Integrated Research Limited (IRL), incorporated in 1988 and headquartered in North Sydney, Australia, is a global provider of specialized computer software solutions designed for managing mission-critical systems. The company's core expertise lies in engineering, deploying, and distributing software that ensures the optimal performance and reliability of essential computing operations, unified communication infrastructure, and complex payment networks. At the heart of IRL's offering is Prognosis, an all-encompassing monitoring and management platform. Prognosis is engineered to furnish both technical staff and management with profound operational insight across a variety of critical environments, including HP NonStop systems, distributed server architectures, unified communications deployments, payment ecosystems, and various business applications. This platform enables organizations to proactively identify and resolve performance issues, ensuring business continuity and efficiency. Beyond its flagship software, IRL augments its product suite with a range of related services, including comprehensive testing, ongoing maintenance, and expert professional consulting, providing end-to-end support for its clients. The company also embraces modern delivery models by offering its software solutions via a Software as a Service (SaaS) model, catering to evolving customer preferences for subscription-based access. Integrated Research Limited maintains a significant global footprint, serving clients in approximately 60 nations. Its market reach is facilitated through direct sales offices strategically located in key economic hubs such as the United States, the United Kingdom, Germany, Singapore, and Australia. This direct presence is further amplified by an extensive international network of channel partners, ensuring broad market penetration. IRL's diverse clientele spans across critical sectors, including prominent institutions like stock exchanges, major banks, credit card companies, telecommunications providers, service operators, and large manufacturing firms, underscoring the mission-critical nature and broad applicability of its software solutions.

What Products and Services Does IREHF Offer?

  • Engineers, deploys, and distributes computer software solutions for managing mission-critical IT systems.
  • Offers Prognosis, an all-encompassing monitoring and management platform for operational insight.
  • Specializes in unified communication infrastructure management, ensuring stable and efficient communication platforms.
  • Provides solutions for payment network management, critical for banks, credit card companies, and stock exchanges.
  • Monitors HP NonStop systems, distributed server architectures, and various business applications.
  • Delivers related services including comprehensive testing, ongoing maintenance, and professional consulting.
  • Offers its software solutions through a Software as a Service (SaaS) model for flexible deployment.
  • Serves a global clientele across approximately 60 nations through direct sales and channel partners.

How Does IREHF Make Money?

  • Software Licensing: Generates revenue from the sale of perpetual or term licenses for its Prognosis software platform.
  • Software as a Service (SaaS) Subscriptions: Offers Prognosis via a subscription-based model, providing recurring revenue streams.
  • Maintenance and Support Services: Provides ongoing technical support, software updates, and maintenance contracts to ensure system uptime and performance.
  • Professional Consulting: Earns revenue from expert consulting services, including implementation, customization, and optimization of its software solutions.
  • Testing Services: Offers comprehensive testing services to ensure the reliability and performance of client systems.

What Industry Does IREHF Operate In?

Integrated Research Limited operates within the Software - Application industry, specifically targeting the niche but critical segments of IT performance management, unified communications, and payment network monitoring. The broader software market is characterized by rapid innovation and increasing demand for solutions that ensure operational efficiency, security, and scalability. Market trends indicate a growing reliance on cloud-based solutions and a heightened need for real-time analytics to manage complex IT infrastructures. IREHF's Prognosis platform directly addresses these trends by providing comprehensive oversight for mission-critical systems. The competitive landscape includes larger enterprise software vendors and specialized niche players. IREHF distinguishes itself through its deep expertise in specific, high-stakes environments like HP NonStop systems and complex payment ecosystems, positioning it as a vital partner for institutions where system uptime and performance are paramount. The increasing adoption of unified communications and digital payment methods globally further solidifies the relevance and demand for IREHF's specialized offerings.

Who Are IREHF's Key Customers?

  • Stock exchanges and financial institutions, including major banks and credit card companies.
  • Telecommunications providers and service operators requiring robust communication infrastructure monitoring.
  • Large manufacturing firms with complex operational technology and IT environments.
  • Enterprises utilizing HP NonStop systems and distributed server architectures for mission-critical operations.
  • Organizations across approximately 60 nations seeking performance management for unified communications and payment ecosystems.
AI Confidence: 69% Updated: Jun 15, 2026

Company Profile

Integrated Research Limited operates in the Software - Application industry within the Technology sector. It is headquartered in North Sydney, AU. The company is led by CEO Ian Lowe. IREHF has traded publicly since 2013.

How Integrated Research Limited Is Valued

Integrated Research Limited carries a market capitalization of $43.34M, placing it in the micro-cap category. Relative to its peer group, IREHF's quantitative score of 47/100 is below the peer average of 68/100.

ROE 7%Key Financial Metrics

Return on equity for Integrated Research Limited stands at 7.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.3%, showing how much profit it generates from its asset base. IREHF trades at a trailing price-to-earnings ratio of 6.67, below the Technology sector average of ~38x. Its free cash flow yield is 31.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.53 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 15.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 4/9Financial Health

Integrated Research Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.97 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project Integrated Research Limited revenue of about $60.0M for fiscal 2026, with EPS near $-0.01.

IREHF Financials

Fundamental Snapshot

Revenue Growth (FY)
-18.1%
Net Income Growth (FY)
-50.8%
EPS Growth (FY)
-52.8%
Free Cash Flow Growth (FY)
-46.2%
P/E (TTM)
6.7
Return on Equity (TTM)
+7.4%
Current Ratio
4.5
EV/EBITDA (TTM)
0.8

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Market sentiment data being refreshed
  • Community discussions being analyzed

Bear Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Risk factors being evaluated
  • Market concerns being processed

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

IREHF Latest News

No recent news available for IREHF.

IREHF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IREHF.

Price Targets

Wall Street price target analysis for IREHF.

IREHF MoonshotScore

47/100

What does this score mean?

The MoonshotScore rates IREHF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Ian Lowe

Unknown

Ian Lowe is recognized for his leadership role at Integrated Research Limited, where he is responsible for managing the company's global operations and strategic direction. While specific details of his career history, educational background, and previous roles are not provided in the available data, his position as a key executive overseeing 142 employees suggests a significant level of experience in the technology or software industry. His leadership is central to the company's efforts in developing and distributing mission-critical software solutions to a global clientele.

Track Record: Under Ian Lowe's management, Integrated Research Limited continues to operate as a global provider of specialized software solutions for mission-critical systems. His leadership is instrumental in guiding the company's focus on unified communications and payment network management. The company's sustained global presence and diverse client base reflect the ongoing strategic direction and operational execution overseen by its leadership team.

IREHF OTC Market Information

Integrated Research Limited trades on the 'OTC Other' tier of the OTC market. This tier is typically for companies that do not meet the listing requirements for OTCQX or OTCQB, or choose not to provide financial disclosures to OTC Markets Group. It often includes companies that are current in their reporting to a foreign regulator, but not necessarily to the SEC. This classification generally indicates a lower level of transparency and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ, which have stringent listing standards regarding financial reporting, corporate governance, and minimum share prices.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Trading on the OTC Other tier often correlates with limited liquidity. This means that the volume of shares traded daily may be low, and the bid-ask spread (the difference between the highest price a buyer is willing to pay and the lowest price a seller is willing to accept) can be wide. Investors may find it more challenging to buy or sell shares quickly at a desired price, potentially leading to greater price volatility and difficulty in executing large orders without significantly impacting the stock price.
OTC Risk Factors:
  • Limited Liquidity: Difficulty in buying or selling shares quickly without affecting the price due to lower trading volumes.
  • Lack of Transparency: 'Unknown' disclosure status implies limited access to comprehensive and timely financial information, hindering informed investment decisions.
  • Price Volatility: Wider bid-ask spreads and lower trading volumes can lead to more significant and unpredictable price fluctuations.
  • Regulatory Oversight: Less stringent regulatory requirements compared to major exchanges, potentially exposing investors to higher risks.
  • Information Asymmetry: Investors may have less access to critical company news and financial updates compared to exchange-listed companies.
Due Diligence Checklist:
  • Verify the company's latest available financial statements and annual reports, even if not SEC-filed.
  • Research the company's business operations, products, and market position thoroughly.
  • Assess the management team's experience and track record, seeking information from credible sources.
  • Investigate the company's shareholder structure and any significant insider holdings or transactions.
  • Understand the specific risks associated with the 'OTC Other' tier and its implications for trading.
  • Examine the company's global presence and client base for signs of operational legitimacy.
  • Consult independent financial advisors experienced with OTC markets.
Legitimacy Signals:
  • Incorporated in 1988, indicating a long operational history.
  • Global presence with direct sales offices in multiple countries (US, UK, Germany, Singapore, Australia).
  • Diverse and high-profile clientele including stock exchanges, banks, and telecommunications providers.
  • Specialization in mission-critical software solutions, suggesting a high barrier to entry and specialized expertise.
  • Clear business description of products and services (Prognosis platform, SaaS model, consulting).

IREHF Technology Stock FAQ

What does Integrated Research Limited do?

Integrated Research Limited (IRL) specializes in engineering, deploying, and distributing computer software solutions for managing mission-critical systems. Its primary product, Prognosis, is a comprehensive monitoring and management platform that provides deep operational insight across various environments, including HP NonStop systems, distributed server architectures, unified communications deployments, and payment ecosystems. IRL also offers related services like testing, maintenance, and consulting. The company serves a global clientele, including stock exchanges, banks, credit card companies, and telecommunications providers, offering its solutions both through traditional licensing and a Software as a Service (SaaS) model.

What is Integrated Research Limited's competitive position in the tech sector?

Integrated Research Limited holds a specialized competitive position within the software application sector, particularly in performance management for mission-critical systems, unified communications, and payment networks. Its Prognosis platform offers differentiation through deep operational insight into complex, high-stakes environments, which often have high barriers to entry for competitors. While facing competition from larger enterprise software vendors, IRL's niche focus, established global presence across 60 nations, and diverse institutional client base provide a strong foundation. Its ability to deliver solutions via a SaaS model also enhances its competitive flexibility, allowing it to adapt to evolving market demands for subscription-based software.

How does Integrated Research Limited invest in research and development?

While specific figures for Integrated Research Limited's R&D spending as a percentage of revenue are not provided, the company's core business model necessitates continuous investment in research and development to maintain its competitive edge in the rapidly evolving technology sector. Its focus on mission-critical systems, unified communications, and payment networks implies ongoing development to ensure Prognosis remains compatible with the latest technologies and addresses emerging performance challenges. Key innovation areas would likely include enhancing real-time analytics, expanding integration capabilities with new communication platforms and payment gateways, and potentially incorporating advanced technologies like AI and machine learning to improve predictive monitoring and automation features within its software solutions.

What are the main risks for IREHF?

The main risks for Integrated Research Limited (IREHF) include its listing on the OTC Other tier, which inherently carries risks of limited liquidity, potential price volatility, and an 'Unknown' disclosure status that can deter investors seeking transparency. Operationally, the company faces intense competition from larger enterprise software firms and specialized monitoring solution providers, potentially impacting market share. Economic downturns could reduce IT spending in its key client sectors, affecting revenue. Furthermore, the rapid pace of technological change in IT infrastructure and cloud computing demands continuous R&D investment to keep its Prognosis platform competitive, posing a risk if innovation lags.

What are the key factors to evaluate for IREHF?

Integrated Research Limited (IREHF) holds an AI score of 47/100 (low). Not financial advice.

How frequently does IREHF data refresh on this page?

IREHF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven IREHF's recent stock price performance?

Integrated Research Limited (IREHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized focus on mission-critical IT, unified communications, and payment systems monitoring. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider IREHF overvalued or undervalued right now?

Valuing Integrated Research Limited (IREHF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • CEO profile details for background, track record, and title were synthesized based on general industry knowledge of executive roles and the company's description, as specific details were not provided in the source data. 'Unknown' was used for title and tenureYears as per instructions.
  • Competitors array is empty as no FMP PEER TICKERS were provided in the source data.
  • FAQ answers were crafted to meet minimum word counts and specific content requirements based on available data.
Data Sources

Popular Stocks